S-100B protein: An early prognostic marker after cardiac arrest

Cardiology Journal

Volumn 17, Issue 5, 2010, Pages 532-536

  Wojtczak Soska, Karolina ^a   Lelonek, MaŁgorzata ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Brain damage; Cardiac arrest; S 100b protein

Indexed keywords

NEURON SPECIFIC ENOLASE; PROTEIN S100B;

BRAIN INJURY; CEREBROVASCULAR ACCIDENT; CONSCIOUSNESS; GLASGOW COMA SCALE; HEART ARREST; HUMAN; IMMUNOASSAY; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; RISK FACTOR;

BIOLOGICAL MARKERS; BRAIN DISEASES; HEART ARREST; HUMANS; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; S100 PROTEINS;

EID: 77957948807     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Shinozaki K, Oda S, Sadahiro T et al. S-100B and neuron-specific enolase as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation: A systematic review. Crit Care, 2009; 13: R121.
2. Prohl J, Röther J, Kluge S et al. Prediction of short-term and long-term outcomes after cardiac arrest: A prospective multivariate approach combining biochemical, clinical, electrophysiological, and neuropsychological investigations. Crit Care Med, 2007; 35: 1230-1237.
3. Roine RO, Somer H, Kaste M, Viinikka L, Karonen SL. Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis. Arch Neurol, 1989; 46: 753-756.
4. Usui A, Kato K, Murase M et al. Neural tissue-related proteins (NSE, G0 alpha, 28-kDa calbindin-D, S100b and CK-BB) in serum and cerebrospinal fluid after cardiac arrest. J Neurol Sci, 1994; 123: 134-139.
5. Dauberschmidt R, Zinsmeyer J, Mrochen H, Meyer M. Changes of neuron-specific enolase concentration in plasma after cardiac arrest and resuscitation. Mol Chem Neuropathol, 1991; 14: 237-245.
6. Sedaghat F, Notopoulos A. S100 protein family and its application in clinical practice. Hippokratia, 2008; 12: 198-204.
7. Gerlach R, Demel G, König HG et al. Active secretion of S100B from astrocytes during metabolic stress. Neuroscience, 2006; 141: 1697-1701.
8. Van Eldik LJ, Wainwright MS. The Janus face of glial-derived S100B: Beneficial and detrimental functions in the brain. Restor Neurol Neurosci, 2003; 21: 97-108.
9. Smit LH, Korse CM, Bonfrer JM. Comparison of four different assays for determination of serum S-100B. Int J Biol Markers, 2005; 20: 34-42.
10. Heizmann CW. S100B protein in clinical diagnostics. Ass Spec Clin Chem, 2004; 50: 49-51.
11. Pfeifer R, Börner A, Krack A, Sigusch HH, Surber R, Figulla HR. Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale. Resuscitation, 2005; 65: 49-55.
12. Shinozaki K, Oda S, Sadahiro T et al. Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation. Resuscitation, 2009; 80: 870-875.
13. Böttiger BW, Möbes S, Glätzer R et al. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation, 2001; 103: 2694-2698.
14. Miao WL, Li HL, Wang HD et al. Role of neuron specific enolase and S100 protein in evaluation of brain damage in patients resuscitated from cardiac arrest. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2007; 19: 749-752.
15. Hachimi-Idrissi S, Van der Auwera M, Schiettecatte J, Ebinger G, Michotte Y, Huyghens L. S-100 protein as early predictor of regaining consciousness after out of hospital cardiac arrest. Resuscitation, 2002; 53: 251-257.
16. Martens P, Raabe A, Johnsson P. Serum S-100 and neuron- specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke, 1998; 29: 2363-2366.
17. Grubb NR, Simpson C, Sherwood RA et al. Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100. Heart, 2007; 93: 1268-1273.
18. Mussack T, Biberthaler P, Kanz KG et al. Serum S-100B and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Crit Care Med, 2002; 30: 2669-2674.
19. Wiesmann M, Steinmeier E, Magerkurth O, Linn J, Gottmann D, Missler U. Outcome prediction in traumatic brain injury: Com parison of neurological status, CT findings, and blood levels of S100B and GFAP. Acta Neurol Scand, 2010; 21: 178-185.
20. Rainey T, Lesko M, Sacho R, Lecky F, Childs C. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24 h) time-point. Resuscitation, 2009; 80: 341-345.
21. Undén J, Romner B. A new objective method for CT triage after minor head injury-serum S100B. Scand J Clin Lab Invest, 2009; 69: 13-17.
22. Brouns R, De Vil B, Cras P, De Surgeloose D, Mariën P, De Deyn PP. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients. Clin Chem, 2010; 56: 451-458.
23. Nash DL, Bellolio MF, Stead LG. S100 as a marker of acute brain ischemia: a systematic review. Neurocrit Care, 2008; 8: 301-307.
24. Dassan P, Keir G, Brown MM. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: A review of S100B. Cerebrovasc Dis, 2009; 27: 295-302.
25. Rosén H, Rosengren L, Herlitz J, Blomstrand C. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke, 1998; 29: 473-477.
26. Püttgen HA, Geocadin R. Predicting neurological outcome following cardiac arrest. J Neurol Sci, 2007; 261: 108-117.
27. Ekmektzoglou KA, Xanthos T, Papadimitriou L. Biochemical markers (NSE, S-100, IL-8) as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation. Resuscitation, 2007; 75: 219-228.
28. Rosén H, Sunnerhagen KS, Herlitz J, Blomstrand C, Rosengren L. Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation, 2001; 49: 183-191.
29. Snyder-Ramos SA, Böttiger BW. Molecular markers of brain damage: Clinical and ethical implications with particular focus on cardiac arrest. Restor Neurol Neurosci, 2003; 21: 123-139.